- Recommendation ID
- IPG612/1
- Question
NICE encourages further research into microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary open-angle glaucoma, including randomised studies. Further research should include details of patient selection and long-term outcomes.
- Any explanatory notes
(if applicable) Evidence on the safety and efficacy of microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary open-angle glaucoma is limited in quantity and quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research.
Source guidance details
- Comes from guidance
- Microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary open-angle glaucoma
- Number
- IPG612
- Date issued
- April 2018
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 30/04/2018 |